Tag: INDIAN PHARMA NEWS
New Meta-Analysis Ranks CAPLYTA®️ Lumateperone First in Efficacy and Metabolic Safety for Adjunctive MDD Treatment
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...
Indian Pharma Hits New Heights : A Record-Breaking $30B Turnover
Indian Pharma Hits New Heights : A Record-Breaking $30B Turnover
PharmaGenDRx News Bureau, – July 26, 2025
11:00 AM IST
India's pharmaceutical exports increased by 9.3% to...